CS
LSTA icon

Credit Suisse’s Lisata Therapeutics LSTA Stock Holding History

Credit Suisse’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-115
Closed -$32K – 4382
2015
Q2 		$32K Buy
115
+24
+26% +$8.92K ﹤0.01% 4485
2015
Q1 		$35K Sell
91
-227
-71% -$123K ﹤0.01% 4301
2014
Q4 		$180K Buy
+318
New +$216K ﹤0.01% 4304
2014
Q3 		– Sell
-146
Closed -$143K – 4567
2014
Q2 		$143K Sell
146
-76
-34% -$73.9K ﹤0.01% 4472
2014
Q1 		$235K Buy
+222
New +$241K ﹤0.01% 4265
2013
Q4 		– Sell
-82
Closed -$105K – 4658
2013
Q3 		$105K Buy
+82
New +$91.1K ﹤0.01% 4098

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Credit Suisse's LSTA Position: Q3 2015 in Review

Credit Suisse sold out of Lisata Therapeutics (LSTA) in Q3 2015, closing a stake of 115 shares — an estimated $32K sold.

Credit Suisse first reported a position in LSTA in Q3 2013 and held it in 6 quarters. The position peaked at $235K in Q1 2014. 43 funds tracked by Wall St. Rank hold LSTA as of Q3 2015.

  • Credit Suisse reported no remaining Lisata Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Credit Suisse sold 115 Lisata Therapeutics shares in Q3 2015, an estimated $32K.
  • Credit Suisse first reported a position in Lisata Therapeutics in Q3 2013 and held it in 6 quarters.
  • Credit Suisse's Lisata Therapeutics position peaked at $235K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2015.

Based on Credit Suisse's 13F filing for Q3 2015, filed 13 Nov 2015.